Thermo Fisher Scientific TMO Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.28B-66.8% | $9.88B+391% | $2.01B-56.3% | $4.6B+10.3% | $4.17B+3.3% | ||
| $4M-20.0% | $5M-28.6% | $7M+133% | $3M-81.3% | $16M+60.0% | ||
| $1.68B+1.1% | $1.67B+2.8% | $1.62B+12.4% | $1.44B+5.5% | $1.37B-4.8% | ||
| $780M+13.9% | $685M— | —— | —— | —— | ||
| $1.93B+2.6% | $1.88B-5.4% | $1.98B+1.9% | $1.95B+4.6% | $1.86B+3.3% | ||
| $942M+6.0% | $889M-10.2% | $990M+4.5% | $947M+8.4% | $874M+15.8% | ||
| $22.32B-22.3% | $28.71B+28.8% | $22.3B-9.3% | $24.58B+5.2% | $23.38B+5.6% | ||
| $10.66B+0.9% | $10.57B+3.8% | $10.18B+5.6% | $9.64B+3.3% | $9.33B+0.3% | ||
| $55.19B+11.8% | $49.36B+0.2% | $49.29B+4.3% | $47.25B+1.6% | $46.49B+1.4% | ||
| -$258M-117% | $1.49B+77.3% | $842M+34.9% | $624M-40.1% | $1.04B-17.9% | ||
| $113.28B+2.7% | $110.34B+7.1% | $103.02B+1.8% | $101.23B+2.2% | $99.04B+1.8% | ||
| $2.93B+8.0% | $2.71B-5.0% | $2.85B+1.7% | $2.81B-2.1% | $2.87B+0.5% | ||
| $177M— | —— | $164M-0.6% | $165M+0.6% | $164M— | ||
| $14.62B-3.7% | $15.19B+2.0% | $14.89B+17.1% | $12.72B-3.5% | $13.17B-1.2% | ||
| $42.95B+9.6% | $39.17B+10.4% | $35.48B+1.3% | $35.03B+3.1% | $33.99B+9.4% | ||
| $213M0.0% | $213M+8.7% | $196M0.0% | $196M-2.0% | $200M-1.0% | ||
| $213M0.0% | $213M+8.7% | $196M0.0% | $196M-2.0% | $200M-1.0% | ||
| $4.42B+3.5% | $4.27B-0.1% | $4.28B+0.2% | $4.27B+7.5% | $3.97B-0.5% | ||
| $767M+46.9% | $522M— | —— | —— | —— | ||
| $60.63B+2.5% | $59.16B+3.1% | $57.35B+2.6% | $55.9B+2.7% | $54.45B+2.5% | ||
| -$2.5B-2.0% | -$2.45B+12.6% | -$2.8B-0.1% | -$2.8B-19.4% | -$2.34B+13.1% | ||
| $25.36B+13.7% | $22.31B0.0% | $22.31B+4.9% | $21.27B0.0% | $21.27B+10.6% | ||
| $51.93B-2.8% | $53.41B+4.7% | $51.02B+1.0% | $50.51B+2.3% | $49.39B-0.4% | ||
| $113.28B+2.7% | $110.34B+7.1% | $103.02B+1.8% | $101.23B+2.2% | $99.04B+1.8% | ||
| $149M+1.4% | $147M-5.2% | $155M-3.1% | $160M-3.0% | $165M-4.6% | ||
| $2.63B-1.1% | $2.66B-4.0% | $2.77B+4.0% | $2.67B+7.1% | $2.49B+2.8% | ||
| $2.68B+2.5% | $2.61B+5.7% | $2.47B-4.9% | $2.6B+8.9% | $2.39B+21.5% | ||
| $780M+13.9% | $685M— | —— | —— | —— | ||
| $1M0.0% | $1M0.0% | $1M0.0% | $1M-75.0% | $4M-33.3% | ||
| $5.97B+1.7% | $5.87B+17.0% | $5.02B+8.8% | $4.62B+2.2% | $4.52B+0.5% | ||
| $19.15B+20.9% | $15.84B-2.5% | $16.24B+7.2% | $15.15B-1.1% | $15.32B-1.4% | ||
| $5.97B+1.7% | $5.87B+17.0% | $5.02B+8.8% | $4.62B+2.2% | $4.52B+0.5% | ||
| $2M-99.2% | $253M-83.8% | $1.56B-13.8% | $1.81B+0.1% | $1.81B+16.1% | ||
| $5.97B+1.7% | $5.87B+17.0% | $5.02B+8.8% | $4.62B+2.2% | $4.52B+0.5% | ||
| $1.57B-21.6% | $2B+5.9% | $1.88B+24.1% | $1.52B+7.0% | $1.42B-28.6% | ||
| $1.03B-12.6% | $1.18B+2.1% | $1.16B+3.3% | $1.12B-0.4% | $1.13B-1.0% | ||
| $1.57B-21.6% | $2B+5.9% | $1.88B+24.1% | $1.52B+7.0% | $1.42B-28.6% | ||
| $3.69B+11.0% | $3.33B+3.7% | $3.21B+0.3% | $3.2B+5.9% | $3.02B-5.5% | ||
| $444M+39.2% | $319M— | —— | —— | —— | ||
| $1.03B-12.6% | $1.18B+2.1% | $1.16B+3.3% | $1.12B-0.4% | $1.13B-1.0% | ||
| $40.07B+11.8% | $35.85B+12.5% | $31.86B-3.5% | $33.02B+5.2% | $31.37B+7.9% | ||
| $1.03B-12.6% | $1.18B+2.1% | $1.16B+3.3% | $1.12B-0.4% | $1.13B-1.0% | ||
| $43.27B+9.7% | $39.46B+10.4% | $35.75B+1.3% | $35.3B+3.0% | $34.26B+9.3% | ||
| $18.71B+0.8% | $18.56B+1.3% | $18.33B+0.5% | $18.23B+0.7% | $18.11B+0.8% | ||
| $445M0.0% | $445M0.0% | $445M+0.2% | $444M0.0% | $444M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $598M+18.2% | $506M— | —— | —— | —— | ||
| $149M+1.4% | $147M-5.2% | $155M-3.1% | $160M-3.0% | $165M-4.6% | ||
| $67M0.0% | $67M— | —— | —— | —— | ||
| $168M+950% | $16M— | —— | —— | —— | ||
| $266M-5.0% | $280M— | —— | —— | —— | ||
| $1.000.0% | $1.000.0% | $1.000.0% | $1.000.0% | $1.000.0% | ||
| 1.2B0.0% | 1.2B0.0% | 1.2B0.0% | 1.2B0.0% | 1.2B0.0% | ||
| 445.5M+0.1% | 445.2M+0.1% | 444.6M+0.1% | 444.4M0.0% | 444.2M+0.1% | ||
| $3.09B-12.5% | $3.53B-7.6% | $3.82B+72.7% | $2.21B-21.5% | $2.82B+27.3% | ||
| $43.27B+9.7% | $39.46B+10.4% | $35.75B+1.3% | $35.3B+3.0% | $34.26B+9.3% | ||
| $39.75B+8.6% | $36.61B+10.7% | $33.08B+2.1% | $32.4B+3.9% | $31.19B+9.3% | ||
| $91M-3.2% | $94M-1.1% | $95M-3.1% | $98M+2.1% | $96M+1.1% | ||
| $229M+18.0% | $194M— | —— | —— | —— | ||
| $2.11B+41.1% | $1.49B+77.3% | $842M+34.9% | $624M-40.1% | $1.04B-17.9% | ||
| $337M-7.9% | $366M— | —— | —— | —— | ||
| $444M+39.2% | $319M— | —— | —— | —— | ||
| $780M+13.9% | $685M— | —— | —— | —— | ||
| $598M+18.2% | $506M— | —— | —— | —— | ||
| $598M+18.2% | $506M— | —— | —— | —— | ||
| $155M-17.1% | $187M— | —— | —— | —— | ||
| $444M+39.2% | $319M— | —— | —— | —— | ||
| $110M+6.8% | $103M— | —— | —— | —— | ||
| $40.07B+11.8% | $35.85B+12.5% | $31.86B-3.5% | $33.02B+5.2% | $31.37B+7.9% | ||
| $7M0.0% | $7M0.0% | $7M+120% | -$35M-6.1% | -$33M0.0% | ||
| 70— | —— | 700.0% | 700.0% | 70— | ||
| $100.000.0% | $100.000.0% | $100.000.0% | $100.000.0% | $100.000.0% | ||
| 50K0.0% | 50K0.0% | 50K0.0% | 50K0.0% | 50K0.0% | ||
| 0— | 0— | 0— | 0— | 0— | ||
| $121M-0.8% | $122M-5.4% | $129M+2.4% | $126M-1.6% | $128M+6.7% | ||
| $65M-7.1% | $70M-17.6% | $85M+14.9% | $74M+25.4% | $59M+18.0% | ||
| $29.41B— | —— | $26.46B+5.7% | $25.04B+2.0% | $24.54B— | ||
| 52%— | —— | —— | —— | —— | ||
| —— | $250M— | —— | —— | —— | ||
| 73.9M+7.1% | 68.9M0.0% | 68.9M+3.3% | 66.8M0.0% | 66.8M+5.8% | ||
| $420M+0.2% | $419M-18.6% | $515M-1.0% | $520M-1.0% | $525M0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Thermo Fisher Scientific's total assets?
- Thermo Fisher Scientific (TMO) holds $113.28B in total assets, up 14.4% year over year.
- How much debt does Thermo Fisher Scientific have?
- Thermo Fisher Scientific carries $43.2B in total debt against $51.9B of shareholders' equity, a debt-to-equity ratio of 0.83.
- How much cash does Thermo Fisher Scientific have?
- Thermo Fisher Scientific holds $3.3B in cash and equivalents.
- Can Thermo Fisher Scientific cover its short-term obligations?
- Its current ratio is 1.53 — current assets exceed current liabilities.
- Where does Thermo Fisher Scientific's balance sheet data come from?
- Every line is extracted from Thermo Fisher Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
